CHESTERBROOK, Pa., Feb. 28, 2014 /PRNewswire/ -- Auxilium Pharmaceuticals , Inc. /quotes/zigman/92812/delayed/quotes/nls/auxl AUXL +2.14% , a fully integrated specialty biopharmaceutical company, today announced financial results for the fourth quarter and full year ending December 31, 2013. The Company also highlighted select commercial, regulatory and clinical development progress and future goals and provided financial guidance for 2014.
Help employers find you! Check out all the jobs and post your resume.
